Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ultralife (ULBI) Enterprise Value (2016 - 2025)

Ultralife has reported Enterprise Value over the past 16 years, most recently at -$9.2 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$9.2 million for Q4 2025, down 38.19% from a year ago — trailing twelve months through Dec 2025 was -$9.2 million (down 38.19% YoY), and the annual figure for FY2025 was -$9.2 million, down 38.19%.
  • Enterprise Value for Q4 2025 was -$9.2 million at Ultralife, down from -$9.1 million in the prior quarter.
  • Over the last five years, Enterprise Value for ULBI hit a ceiling of -$4.9 million in Q3 2022 and a floor of -$15.7 million in Q3 2021.
  • Median Enterprise Value over the past 5 years was -$8.5 million (2025), compared with a mean of -$8.9 million.
  • Biggest five-year swings in Enterprise Value: tumbled 122.92% in 2021 and later surged 68.69% in 2022.
  • Ultralife's Enterprise Value stood at -$8.3 million in 2021, then skyrocketed by 40.57% to -$4.9 million in 2022, then crashed by 106.8% to -$10.2 million in 2023, then skyrocketed by 34.58% to -$6.7 million in 2024, then crashed by 38.19% to -$9.2 million in 2025.
  • The last three reported values for Enterprise Value were -$9.2 million (Q4 2025), -$9.1 million (Q3 2025), and -$10.7 million (Q2 2025) per Business Quant data.